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Abstract
Biobehavioral research, especially that which is conducted with prisoners,
has become much more closely regulated in the last 30 years. State and
federal law, as well as professional standards, regulate the conduct of
many types of research; in the case of prisoners, this regulation is even
more stringent. However, currently no mandatory, uniform, national
regulatory or oversight process exists, and many privately funded research
endeavors are operating in a regulatory void. In response to this, the
National Bioethics Advisory Commission has argued for the creation of a
single, national, independent regulatory body to oversee all human
participant research, regardless of funding source. As ethicolegal research
standards evolve alongside advances in science and technology, an
appreciation of the history of prisoner research and an awareness of
current standards is critical to conducting ethical prison research.
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Ethical and Legal Standards for Research in Prisons
Contemporary behavioral science research rests upon four
fundamental tenets: (i) the independent review process (by ostensibly
disinterested parties), (ii) informed consent (comprised of a competent,
knowing, and voluntary decision to participate), (iii) minimization of
harm, and (iv) privacy and confidentiality. These ideals apply equally to
all human participants; however, in the case of special populations who
may be more vulnerable, such as prisoners, extra attention must be paid to
ethical and legal issues unique to their situation. Any environment in
which prospective participants do not function in a fully autonomous
manner necessitates careful attention to ensure voluntary participation.
This is particularly true in correctional settings, where the
environment may be perceived as inherently coercive (Stanley, Sieber,
& Melton, 1996).
Historical Roots of Research in Prisons
Our current standards governing research have grown out of a long
and troubled history of human experimentation (see, e.g., Garnett, 1996;
Hoffman, 2000). The need for an established code of conduct is wryly
noted by Brakel (1996):
The use of human subjects in behavioral and biomedical research
is today circumscribed by a quite elaborate set of rules, regulations,
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and guidelines. These legal and ethical strictures give force to what
are perceived as certain fundamental moral principles guiding
man’s treatment of his fellow man. The source of these principles
is variously traced to “natural law,” man’s “humanity,” or some
other hopeful metaphysical construct whose observance would be
considered, or so the aspiration is, a matter of course for all
civilized societies. However, the articulation of these principles as
in any way binding, as law, has generally come in the aftermath of
historical experience that directly contradicts the benign
assumption that they are universally shared or adhered to (p. 5).
The use of prisoners in research is by no means a modern phenomenon.
Although investigators have become much more sensitized to the
importance of respecting the diminished autonomy of prisoners, the truth
is that physicians and researchers have utilized these “ideal” environments
extensively for millennia. Hoffman (2000) notes the use of incarcerated
populations dating back to ancient Persia, where physicians often utilized
prisoners as research participants. Poisons were tested on captives of the
Roman Empire, and in 18th century Europe prisoners were infected with
venereal disease, cancers, typhoid, and scarlet fever to study disease
course and outcome. The notorious experiments conducted by Nazi
physicians in the mid-20th century are amongst the best-known abuses of
prisoners in the name of science.
The legacy of prisoner experimentation in the United States is also
troubling. Notwithstanding the aversiveness of the environment,
correctional institutions possess many desirable features for behavioral
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researchers attempting to control experimental conditions. In fact, it has
been noted, “prisons are almost ideal places to conduct research. Life ... is
subject to few variations. The population is relatively stable... . The
imposition of experimental procedures that might inconvenience freeliving subjects is not a burden on prisoners ... . It is also less expensive”
(Annas, Glantz, & Katz, 1977, p. 103). The Encyclopedia of Bioethics
cites the first recorded use of prisoner participants in 1914 (Reich, 1995).
The Mississippi Department of Corrections allowed researchers to induce
pellagra in 12 prisoners (a disease-causing dementia and, potentially,
death). Despite experiencing severe symptoms—and submitting repeated
requests to be released from the research—the prisoners were not allowed
to terminate their participation. All participants survived and were granted
pardons (see Hoffman, 2000).
Over the next 60 years, prison research flourished in the United
States. Unlike European countries, which tended to avoid prisoner
experimentation (no doubt sensitized by the Nuremberg Trials), most
researchers in the United States had no such qualms about using this
population (see Schroeder, 1983). There were few, if any, publicly voiced
concerns about prisoner participation until the mid-1960s. Studies
involving thousands of participants (many sponsored by the U.S.
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government) included tropical diseases (e.g., malaria, sleeping sickness),
sexual functioning and reproductive capacity (e.g., testicular transplants
and testicular irradiation), plutonium injections, and radiation exposure
(Advisory Committee on Human Radiation Experiments [ACHRE],
1996). Following a shift in funding regulations by the Food and Drug
Administration (FDA) in 1962, agencies not funded by the federal
government began to use prisoners almost exclusively in drug toxicity
clinical trials. In 1969, 42 prisons in the U.S. provided prisoner
participants for 85% of all new drug trials (Hoffman, 2000). By 1972,
more than 90% of all investigational drugs were first tested on inmates
(ACHRE, 1996).
Although remarkable, this historic reliance upon prison
populations is not surprising. In 1947, a committee appointed by the
governor of Illinois examined the famous World War II-era study
involving the infection of prisoners with malaria (Leopold, 1958). The
study was pronounced ethically sound—in fact, ideal—and consistent with
rules of the American Medical Association (AMA) regarding human
experimentation. The report was ultimately published by the AMA and
became, in the United States, the voice of the medical establishment
regarding the acceptability of prisoner participation. Perhaps the most
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interesting aspect of this investigation is the fact that the committee was
chaired by Andrew Ivy, an American physiologist, and the prosecution’s
chief expert witness on medical ethics at the Nuremberg Trials in post-war
Germany (ACHRE, 1996). Given the official stamp of approval by the
leading medical authority in the country, prison research continued
unabated throughout the 1960s. However, by the early 1970s, due to
increasing public scrutiny and outcry, the moral–ethical debate on utilizing
vulnerable populations as research participants moved to the forefront of
U.S. bioethics (Garnett, 1996).
But prisoners were not the only group to be treated unethically by
investigators. The 1970s witnessed a growing public awareness of
research employing other vulnerable populations in America. The
Tuskegee Syphilis Study, conducted in impoverished Macon County in
Alabama, has been termed “America’s Nuremberg” (Caplan, 1992). The
1932 government-funded study investigating the course of untreated
syphilis recruited 399 largely poor, rural, Black men promising “special
free treatment” for the problem of “bad blood.” In fact, these men were
never informed that they had syphilis, received no treatment (other than
placebo), but were actively led to believe that their cases were being
therapeutically managed. For forty years, despite the discovery that
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penicillin was an effective treatment for syphilis in 1947, the U.S. Public
Health Service denied the participants treatment.
Despite a few isolated calls for inquiry into the ethics of the study
as early as 1936 with publication of the first findings, both the Centers for
Disease Control and Prevention (CDC) and the AMA were officially
supporting the study and calling for its continuation as late as 1969. A year
later the first news articles broke the story, and public outrage quickly
mounted. By 1972, the study was halted: 28 men had died of syphilis,
another 100 died of related complications, 40 spouses had contracted
syphilis, and 19 children had been infected perinatally. The National
Association for the Advancement of Colored People (NAACP) launched a
class action suit in 1973 and received a nine-million-dollar settlement with
lifetime medical benefits and burial insurance for participants and affected
family members (CDC, n.d.). In 1997, President Clinton offered the
first official apology to the participants and their families, calling the
government’s actions “deeply, profoundly, [and] morally wrong ... . What
the United States government did was shameful” (Clinton, 1997).
In 1974, largely in response to the Tuskegee scandal, the federal
government established the National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research. The members
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considered evidence that showed that many thousands of individuals had
been subjected to involuntary, undisclosed procedures and treatments—
some benign, others less so—all in the name of science. The Commission
was unified in condemning the identified abuses of participants and, in
addition to other identified vulnerable populations, it singled out prison
research in its consideration of the coercive aspects of institutions.
After an exhaustive survey of the field, and in light of what they
believed was the impossibility of prisoners giving truly informed,
voluntary consent (given the innately coercive environment of prisons),
the Commission recommended a halt to nearly all research involving
prisoners. Research in correctional institutions decreased dramatically.
Notably, by 1980, only 15% of all drug testing was conducted with
prisoner participants (see Schroeder, 1983). The reason for this rapid
deceleration of research activity—and the guiding principles that emerged
from the Commission’s report—derived in part from the Nuremberg Code
(1949), a body of ethical and legal regulation established by the
Nuremberg Military Tribunal during the trial of Nazi physicians in postwar Germany. Interestingly, Moreno (1997) notes, at the time that the
Nuremberg Code was drafted it was considered largely irrelevant by
researchers in the United States because they believed themselves immune
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to the problems faced by the European community as the latter struggled
to come to terms with the atrocities perpetrated under the guise of medical
experimentation.
The evolution of ethical standards.
Any history of codified law and regulation concerning human
research participation must include consideration of the context in which
each set of guidelines evolved and the problems they were designed to
address. The ethics code generally accepted as the primogenitor of modern
standards grew out of one of the most troubling periods of human history.
The Nuremberg Code.
In many ways the Nuremberg Code (1949) is the prototypical
expression of values relating to human experimentation. Indeed, it
continues to serve as the gold standard against which all subsequent
policies and practices are judged. Nonetheless, its creation was predicated
on unprecedented malevolence in medical experimentation. It is worthy of
note, and particularly salient to the present discussion, that the first
internationally recognized code of conduct for human experimentation
was premised upon the ethical treatment of prisoners.
In 1946, 23 Nazi physicians were called to account for the
experimentation atrocities committed against thousands of prisoners of
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war. The prosecution charged them with failing to conform procedures to
existing conventions and norms. In particular, in 1931, the German
government itself had established a sophisticated and comprehensive
policy to govern human experimentation following the tuberculosisvaccine-related deaths of 75 children. These regulations included, among
others, the requirement of informed consent. This policy along with most
others had been dispensed with when the Nazi party seized power.
Nonetheless, it was relied upon by the Nuremberg Tribunal as evidence
that the physicians had violated an existing regulatory standard.
The defense countered with the argument that no such established
code of conduct existed and that various guidelines that did exist were
contradictory and ambiguous (Moreno, 1997). Unfortunately, they were
correct. The prosecution prevailed, but the Tribunal had been made
aware of a terrible regulatory void in local and international policy
regarding medical experimentation.
The outgrowth of the Nuremberg trials was a codified set of ethical
conditions that held, as a priority, respect for the dignity of all persons.
Specifically, it emphasized the necessity of informed and voluntary
consent of participants who “should be so situated as to be able to exercise
free power of choice” (Nuremberg Code, 1949, Prin. 1). The first
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articulated principle clearly sets the tone for subsequent recommendations:
“The voluntary consent of the human subject is absolutely essential” (Prin.
1). The Code leaves no room for decisionally impaired participants and is
considered by many scholars today as “unduly restrictive” (Gray, Lyons,
& Melton, 1995, p. 36). Nonetheless, out of this war-era tragedy evolved
an authoritative policy for conducting ethical research with human
participants— received and acknowledged by the international
community.
The spirit of the Nuremberg Code is mirrored in the provisions of
the United Nations’ Universal Declaration of Human Rights (1948), which
facilitated the acceptance of these principles by each of the 51 signatory
nations at that time.
By 1953, the first U.S. federal policy on human experimentation
was published by the Clinical Center of the National Institutes of Health
(NIH), drawing upon the ten principles of the Nuremberg Code (NIH,
1995). The following year, the World Medical Association (WMA)
proposed its own set of guidelines, maintaining the spirit, but modifying
the stricter, legalistic tone of the Nuremberg Code (see Babbo, 2000). This
proposal would undergo several revisions before being adopted by the
18th World Assembly in 1964, as The Declaration of Helsinki.
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The Declaration of Helsinki.
Although the Nuremberg Code (1949) was an excellent starting
point for articulating ethical research principles, the World Medical
Association (WMA) acknowledged a need for a more comprehensive set
of guidelines. The Declaration of Helsinki was a document created by
physicians for physicians, and was adopted by the WMA in 1964 (rev.
1975, 1983, 1989, 1996, and 2000). It consists of 32 principles, and is
considered more lenient than its predecessor (Ryan, 1994/1995). Although
it incorporates all previously articulated goals and principles of ethical
research, the language is simultaneously somewhat more complex and
vaguer. Notably, it does not preclude the participation of decisionally
impaired individuals (fully three principles deal with the matter). Rather,
the Declaration of Helsinki requires either consent from a legally
authorized representative (along with the participant’s assent when
possible) or the option to obtain consent or assent or both—as soon as the
participant or legal representative is able to give it.
Although not specifically designed to address prison research, a
few principles appear relevant to institutional settings. The Declaration
refers to populations that are “vulnerable and need special protection,”
including those “who may be subject to giving consent under duress,” and
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thus should be treated with special care (§A[8]). As an additional
safeguard, experimental protocols are to be submitted for an ethics review
by an Institutional Review Board (IRB) (§B [13]). One of the more unique
contributions stipulates “in any research on human beings, each potential
subject must be adequately informed of the aims, methods, sources of
funding, any possible conflicts of interest, [and] institutional affiliations of
the researcher” (§B [22]).
Of the codified principles and guidelines that exist, this may be the
strongest statement of the need for unambiguous and unequivocal
disclosure by researchers. Although ideal, it is rare for this degree of
explicit information to be communicated to research participants in
general, and rarer still for it to be communicated to prisoner participants in
particular. Not only is this degree of information not routinely
disseminated, certain provisions—the Ethical Principles of Psychologists
and Code of Conduct, for example—explicitly allow for deception of
participants (APA, 1992, §6.15 [a][c]). Noteworthy in this regard, is that
in the 2002 revision of the ethics code, the APA has added the stipulation
that deception is warranted only if the “scientific, educational, or applied
value” is “significant” and participants are allowed the option to withdraw
their data upon debriefing (APA, 2002, §8.07 [a][c]). Although many
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studies in the social sciences rely upon disinformation as part of the
experimental design, every effort should be taken to ensure that certain
critical information not implicated in the methodology (e.g., investigator
affiliation) be communicated clearly to all participants—especially in
correctional institutions— as there is strong evidence that
misunderstanding is common (Stanley et al., 1996).
The National Research Act.
By the early 1970s, the American public was becoming aware of
the various abuses of research participants, especially those recruited from
vulnerable populations (see ACHRE, 1996; Babbo, 2000; Brakel, 1996;
Garnett, 1996; Moreno, 1997; Schroeder, 1983). Amongst others, reports
of abuses in the Tuskegee Syphilis Study were circulating, and the public
was calling for an official investigation. The U.S. government responded
swiftly, and the Senate Committee on Labor and Human Resources held
hearings on this and other studies alleged to have involved the
mistreatment of children and prisoners.
The outcome of those hearings was the formation of the National
Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research (NCPHSBBR), and the enactment of The National
Research Act in 1974. Specific additional protections for certain
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vulnerable populations were added: in 1975— pregnant women; in 1978
—prisoners; and in 1983 —children. This policy was revised, codified,
and received approval in 1981, as Title 45 Part 46 of the Code of Federal
Regulations (45 C.F.R. 46, 2001) [addressed below].
The Belmont Report.
During the years 1974–1978, the NCPHSBBR was charged with
evaluating the Department of Health, Education, and Welfare (DHEW,
now the Department of Health and Human Services, DHHS), offering
suggestions for improvements, and issuing periodic reports. One such
publication, The Belmont Report: Ethical Principles and Guidelines for the
Protection of Human Subjects of Research (NCPHSBBR, 1979), reflected
a significant theoretical contribution to research policy.
Unlike its predecessors, the Belmont Report did not offer an
exhaustive or detailed listing of specific articles, but rather suggested three
fundamental ethical principles required of all human experimentation: (i)
Respect for Persons, (ii) Beneficence, and (iii) Justice. It was hoped that
“broader ethical principles [would] provide a basis on which specific rules
[could] be formulated, criticized, and interpreted” (Introduction). The
Belmont Report embodies a general and liberal ethic in a thoughtful and
flexible manner—encouraging more questions than it seeks to answer. The
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simplistic maxim “do no harm” was carefully considered. In the final
analysis, drafters suggested that rigid, legalistic rules do little to resolve
the complex ethical challenges that are far more common than not. The
Belmont Report is considerably less concrete or legalistic than its
predecessors—but in no way is it ethically lax.
Respect for Persons.
The first principle in the Belmont Report (1979) was designed to
acknowledge the importance of the autonomy and dignity of the
individual. At the same time, it stipulates special protections for those with
diminished autonomy. This wording is significantly different from
previous language that referred to individuals as decisionally impaired, or
simply as members of vulnerable populations. By focusing on the degree
of autonomy possessed, the Report avoided the implication that there was
something intrinsically deficient about these individuals. The first
principle articulates the consent process, confirming the importance and
centrality of an informed, competent, and voluntary participant in
research:
On the one hand, it would seem that the principle of respect for
persons requires that prisoners not be deprived of the opportunity to
volunteer for research. On the other hand, under prison conditions they
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may be subtly coerced or unduly influenced to engage in research
activities for which they would not otherwise volunteer .. . . Whether to
allow prisoners to “volunteer” or to “protect” them presents a dilemma.
Respecting persons, in most hard cases, is often a matter of balancing
competing claims urged by the principle of respect itself (§B [1]).
Beneficence.
The second principle was specifically chosen by the Commission
to reflect a level of care higher than that of mere obligation. The intent
was to provide a synthesis of two complementary expressions: (i) do no
harm, and (ii) maximize potential benefits while minimizing possible risk
or harm. Even with this seemingly simple directive, the Report notes the
ethical difficulty that, despite best intentions, “learning what will ... .
benefit [participants] may require exposing persons to risk” (§B [2]). In
other words, simply to be aware of potential risks necessitates previous
experience with exposure to them.
Justice.
The concluding principle was intended to reflect the importance of
fairly and equally distributing the burdens and benefits of experimental
research. As an example, the authors cited the Tuskegee Syphilis Study, an
investigation that targeted a severely disadvantaged population despite the
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fact that the disease was affecting all segments of the population.
Similarly, for many years, indigent and institutionalized people were often
used in medical studies, the benefits of which were typically enjoyed by
affluent private patients. In sum,
The selection of research subjects needs to be scrutinized in order
to determine whether some classes ... are being systematically
selected simply because of their easy availability, their
compromised position, or their manipulability, rather than for
reasons directly related to the problem being studied (§B [3]).
Finally, the Report noted that, unless there were good reasons for an
exception, individuals unlikely to benefit from current or future
applications of the research should not be included as participants.
Reflecting this concern for fairness and equity, the recent revision of the
APA’s ethics code has incorporated a new, similarly named principle,
Justice, which articulates the entitlement of “all persons to access to and
benefit from the contributions of psychology and equal quality in the
processes, procedures, and services” (APA, 2002, Prin. D).
APA Ethical Principles of Psychologists and Code of Conduct
In the course of its history, the APA has endeavored to establish a
high standard for the ethical treatment of research participants. As noted,
the ethics code now incorporates an overarching principle of Justice.
However, overall, the latest iteration of the code may reflect some
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movement away from protection of research participants.
Ethical responsibility and compliance with existing law.
The 1992 code, in a spirit similar to that of the Belmont Report,
promulgated guidelines for the ethical treatment of research participants
which highlighted the importance of preserving the “dignity and welfare”
of individuals (§6.07 [a]). Although specific groups were not identified as
vulnerable, the code stated “psychologists [should] consult [those] with
expertise concerning any special population under investigation” (§6.07
[d]). Special mention was made of the need to conform research endeavors
to “federal and state law and regulations,” as well as existing “professional
standards” (§6.08). This stated deference to existing state and federal law
may have promised more than it could deliver. Given the sometimes
inconsistent and ambiguous statements of policy, and the fact that the
federal code currently still applies only to federally funded or conducted
research, this well-intentioned aspiration may have been somewhat
hollow. The point, however, may be moot with the introduction of the new
2002 code of ethics.
The APA, in its most recent revision, has deleted significant
sections of the 1992 code, including those enumerated above. Although
elements of other standards have been subsumed under different sections,
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the standards pertaining to the “dignity and welfare of participants” (§6.07
[a]), and the need to consult with experts in the area under investigation
(§6.07 [d]), have been eliminated. Of particular note, the standard
addressing compliance with existing federal and state law (§6.08),1 has
been deleted. What impact, if any, these changes will have on behavioral
science research is difficult to predict.
Informed consent.
The attention given to informed consent has become successively
more focused with each iteration of the code. Specific elements to be
included as part of the disclosure process include (i) purpose of the
research, expected duration, and procedures, (ii) right to withdraw at any
time, (iii) foreseeable consequences of declining or with- drawing, (iv)
reasonably foreseeable risk or adverse effects, (v) prospective benefit from
participation, (vi) limits of confidentiality, (vii) incentives, and (viii)
names of study contacts (APA, 2002, §8.02 [a]). Dispensing with
informed consent is addressed (APA, 2002, §8.05), as is consent to be

APA, 1992, Ethical Principles of Psychologists and Code of Conduct
§6.08: Compliance With Law and Standards states ‘‘Psychologists plan
and conduct research in a manner consistent with federal and state law
and regulations, as well as professional standards governing the conduct
of research, and particularly those standards governing research with
human participants and animal subjects’’ [deleted from Code, 2002]
1
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filmed or recorded (APA, 2002, §8.03). This emphasis on content and
documentation of consent is consistent with the more legalistic principles
articulated in earlier codes. However, as has been pointed out, the spirit of
informed consent is much more challenging to honor (Gray et al., 1995;
Stanley et al., 1996). Respect for the individual requires much more than
the conveyance of information—it necessitates a dialogue between
researcher and participant. That dialogue necessarily becomes much more
complicated when deception is a component of the study’s design.
Deception in research.
As is evident in the APA’s ethical standards, deception in research
is acknowledged as necessary at times. Kazdin (2003) notes the inherently
difficult role assumed by behavioral researchers who, by the very nature of
the research they conduct, must often withhold or distort information and
implement treatment conditions that may lead to unpleasant experiences
for the participant. Nonetheless, he observes, “the problem with forms of
deception and surprises in an experiment is that the professional context of
an experiment may lead people to expect full disclosure, candor, and
respect for individual rights” (p. 503). The onus, he asserts, must remain
on the investigator, at all stages, to justify the use of deception, and he
proposes three criteria, which mirror the APA code: (i) the study must
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propose to obtain important information, (ii) less deceptive or nondeceptive measures have been seriously considered and ruled out, and (iii)
the aversiveness of the deception must be judged relative to the
importance of the information gathered (p. 505).
Code of Federal Regulations, Title 45, Part 46
As previously noted, the research provisions in the Code of Federal
Regulations (see Protection of Human Subjects, 45 C.F.R. 46, 2001) grew
out of the National Research Act (1974). With each subsequent revision,
the regulations have become more comprehensive and specific.
Jurisdiction.
Originally only applicable to DHHS-funded research, the
regulatory authority of the amended code was extended in 1991 to all
federally funded research. Since its creation, the code has been adopted
and codified individually by many additional government agencies and
departments as the “Common Rule”2 (45 C.F.R. 46, Subpart D, 2001). As

2

The ‘‘Common Rule’’ (Federal Policy) for the Protection of

Human Subjects is also codified, for example, at 7 CFR 1c (Department of
Agriculture); 10 CFR 745 (Department of Energy); 14 CFR 1230 (National
Aeronautics and Space Administration); 15 CFR 27 (Department of
Commerce); 16 CFR 1028 (Consumer Product Safety Commission); 22 CFR
225 (International Development Cooperation Agency; Agency for
International Development); 24 CFR 60 (Department of Housing and Urban
Development); 28 CFR 46 (Department of Justice); 32 CFR 219 (Department
of Defense); 34 CFR 97 (Department of Education); 38 CFR 16 (Department
of Veterans Affairs); 40 CFR 26 (Environmental Protection Agency); 45 CFR
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the current authority governing human research, the federal policy, or
Common Rule, embraces three general issues: (i) informed consent, (ii)
institutional review boards, and (iii) institutional assurances.
Currently, the federal policy governs most (but not all) (i) research
conducted by federal government departments, (ii) federally funded
studies, and (iii) commercially sponsored research conducted on behalf of
drug and medical device companies. Any organization or institution
conducting research that is federally funded must pledge its commitment
to the principles by signing and filing a Federalwide Assurance (FWA or
“assurance”). The purpose of this filing is to formalize the researcher’s
commitment to the protection of all human participants involved in
research.
Unlike the aforementioned research activities, private and
nonfederally related or funded research exists in a sort of regulatory limbo,
with some types of investigation subject to the code and others not. Even
where guidelines do exist, their relevance and application at the state level
is often ambiguous, confusing, and inconsistent.
However, in general,

690 (National Science Foundation); 49 CFR 11 (Department of
Transportation).
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If an institution receives [D]HHS funding or support to conduct
human subjects research then it must have an OHRP [Office for
Human Research Protections]-approved assurance under which it
pledges to conduct its federally funded or supported research in
accordance with the human subjects’ protections of 45 C.F.R. 46 ...
. Alternatively, an institution that receives no federal funding or
support for human subjects’ research may or may not pledge to
uphold the standards articulated in the regulations at 45 C.F.R. 46.
Where such an institution does not avail itself of the assurance
process and pledge to uphold the regulations at 45 C.F.R. 46,
OHRP would have no jurisdiction (E. I. Summers, J.D., OHRP,
personal communication, April 18, 2002).
Scope.
The federal policy governing research is built around three
mechanisms for protection of participants: (i) voluntary informed consent,
(ii) the institutional review process, and (iii) quality assurance oversight at
the federal level by the Office for Human Research Protections (OHRP,
formerly the Office for Protection from Research Risks, OPRR), a newly
formed office within the DHHS. Unlike other guidelines that address these
issues in general terms, the federal code is quite explicit—especially in the
case of prisoner participants.
Informed consent.
Federal regulations governing informed consent as well as
guidelines concerning the involvement of prisoners as research
participants are clearly articulated. The code specifies a near-exhaustive
list of information to be included—and a warning that there should be no
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“exculpatory language through which the subject ... is made to waive or
appear to waive any of the subject’s legal rights, or releases or appears to
release the investigator, the sponsor, the institution or its agents from
liability for negligence” (45 C.F.R. §46.116, 2001). Informed consent is
often conceptualized as consisting of three basic principles: (i) disclosure,
(ii) competence, and (iii) voluntariness. Disclosure refers to the
responsibility of the researcher to convey information regarding risks,
benefits, and possible alternatives to the treatment proposed.
This process is ideally an interactive communication, as opposed to
the far more common rote recitation of a standard paragraph crafted by
researchers or an institutional oversight committee. The second principle,
competence, refers to the ability of participants to understand (i.e.,
comprehend the information), appreciate (or relate information to
themselves in a personally meaningful manner), and apply reason (or
manipulate the information logically) to arrive at a decision consistent
with their own preferences. Finally, to give an informed consent
voluntarily implies an absence of coercion or deception in the decisional
process (see Stanley et al., 1996).
Whether institutionalized individuals can freely and voluntarily
consent to participation, given their diminished autonomy, is a matter of
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longstanding debate (see Brakel, 1996; Gray et al., 1995; Hoffman,
Schwartz, & DeRenzo, 2000; Schroeder, 1983; Stanley et al., 1996).
Regarding prisoner participation in research, 45 C.F.R 46 (2001) explains
that
Inasmuch as prisoners may be under constraints because of their
incarceration which could affect their ability to make a truly
voluntary and uncoerced decision whether or not to participate as
subjects in research, it is the purpose of this subpart to provide
additional safeguards for the protection of prisoners involved in
activities to which this subpart is applicable (§46.302).
In an effort to mitigate any undue influence deliberately or unknowingly
perpetrated, the code stipulates the following conditions:
Any possible advantages accruing to the prisoner through his or
her participation in the research, when compared to the general
living conditions, medical care, quality of food, amenities and
opportunity for earnings in the prison, are not of such a magnitude
that his or her ability to weigh the risks of the research against the
value of such advantages in the limited choice environment of the
prison is impaired (§46.305[a][2]).
Regarding the incentive of “good time” often utilized in correctional
settings, and a potential source of coercion, the federal policy demands
that adequate assurance exists that parole boards will not take into account
a prisoner’s participation in the research in making decisions regarding
parole, and each prisoner is clearly informed in advance that participation
in the research will have no effect on his or her parole (§46.305 [a] [6]).
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Institutional review boards.
To avoid conflicts of interest and ensure adequate representation of
participants on IRBs, 45 C.F.R. 46 (2001) is explicit: (i) a majority of the
Board must have no institutional affiliation with the correctional facility,
and (ii) at least one member of the Board must be a prisoner (current or
former), or a prisoner representative with appropriate experience and
interests (§46.304). In addition to monitoring board composition, IRBs are
charged with ensuring that the magnitude of risk posed to prisoners is no
greater than the level of risk a non-prisoner would be willing to assume
(§46.305 [d] [3]), and that participant selection is fair and free from
intervention by prison officials (§46.305 [d] [4]).
Quality assurance oversight.
As noted, all recipients of federal research funds are required to
file a Federalwide Assurance (FWA) as a formal commitment to the
principles of the Common Rule. The recipient of federal funds must also
ensure that subcontractors and collaborators (or each legally separate
entity) hold an OHRP-approved Assurance prior to their induction into the
research program. Once approved, the FWA will be listed on OHRP’s
website, and only then can human participant research begin.
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Permissible types of research.
According to the federal policy, the subject matter of prison
research must conform to permissible categories of inquiry, of which there
are four: (i) studies of the possible causes, effects, and processes of
incarceration, and of criminal behavior, provided the studies present no
more than minimal risk, (ii) studies of prisons as institutional structures or
of prisoners as incarcerated persons, provided the studies present no more
than minimal risk, (iii) research on conditions particularly affecting
prisoners as a class (e.g. hepatitis, AIDS), or (iv) research on practices
both established and innovative, which have the intent and reasonable
probability of improving the health or well-being of the participants (45
C.F.R. §46.306, 2001).
A Call for National Oversight
As the foregoing discussion indicates, prison research has been
closely scrutinized, and is now highly regulated by the federal
government. However, inconsistencies at state and federal levels of
implementation still exist. Although not binding upon private institutions,
many have adopted modified and integrated versions of the
research guidelines found in such documents as the Nuremberg Code,
Belmont Report, and the Common Rule, as guides to maintaining ethical
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integrity in the conduct of research with human participants. Nonetheless,
others have offered the observation that current laws and regulations
governing human experimentation are a “crazy-quilt of hortatory codes
and maxims, scattered federal laws and regulations” (Garnett, 1996, p.
473).
Indeed, the lack of a mandatory uniform national regulatory and
oversight process may become increasingly more problematic as we move
toward even greater privatization of research endeavors (see Ethical and
Policy Issues in Research Involving Research Participants, 2001; Hoffman
et al., 2000; Moreno, 1998), and correctional facilities (Brakel, 1996).
However, efforts to remedy this situation may be forthcoming; Moreno
(1998) reports there is “growing Congressional concern about research
that does not come under federal informed consent requirements, either
because it is privately funded or because the sponsors do not plan to
pursue FDA approval for a drug or device” (pp. 17–18). Recently, this
concern was echoed by the National Bioethics Advisory Commission
(NBAC, 2001).
A fundamental flaw in the current oversight system is the ethically
indefensible difference in the protection afforded participants in federally
sponsored research and those in privately sponsored research that falls
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outside the jurisdiction of the Food and Drug Administration (FDA). “As a
result, people have been subjected to experimentation without their
knowledge or informed consent .. . . This is wrong. Participants should be
protected from avoidable harm, whether the research is publicly or
privately financed” (66 F.R. 46001).
Prisoners as Research Participants: Early Cases
Early lawsuits reveal the compelling interests that fostered the
development of contemporary protective regulation. These early cases laid
the groundwork and stimulated public interest in human research
participant protections. On occasion, they had unexpected outcomes.
Kaimowitz v. Michigan Department of Mental Health (1973)
One of the earliest and best-known prison research cases involved
an individual, J. Doe, who had been committed to a state facility for nearly
two decades with a diagnosis of “criminal sexual psychopath,” and was
identified as a potential research participant for a study of “uncontrollable
aggression.” The study proposed to compare levels of male hormones in
drug versus psychosurgery conditions. Doe was designated as appropriate
for the surgery treatment group. Investigators obtained IRB approval and
informed consent from both Doe and his parents. However, when the
public learned of this investigation, opposition mounted. As the result of
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negative publicity, the study was ultimately terminated, and the court
agreed to grant a writ of habeas corpus.
Surprisingly, despite IRB approval and the informed consent
obtained, the court ruled that the high-risk procedure combined with the
uncertainty of outcome to create an unacceptable level of risk to visit upon
Mr. Doe. It observed, as a given, the impossibility of ever obtaining “truly
informed consent from such populations” (Kaimowitz, 1976, p. 148). In
the opinion of the court, the experimental nature of the surgery rendered it
impermissible (implying that traditional procedures might have been
acceptable).
Over time, a paternalistic approach has given way to an
assumption of more autonomy—albeit diminished—on the part of
incarcerated participants. More than two decades later, the National
Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research, rejected the idea that prisoners are incapable of
informed and voluntary consent (see, e.g., Winick, 1997).
Bailey v. Lally (1979)
On the heels of Kaimowitz, prisoners brought a class action against
the State of Maryland alleging that research participants had suffered a
violation of due process, privacy, and protection against cruel and unusual
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punishment. The latter Eighth Amendment challenge was closely
scrutinized by the court, which eventually ruled against the plaintiffs. The
facts of the case included concerns about the physical state of the
Maryland House of Correction (MHC), established in 1879, and originally
intended to hold approximately 1000 inmates. By the early 1970s, the
facility was at 160% capacity, with no hot water, heat, or cooling systems
for the prisoners. Many inmates had no regular activities (i.e., school or
work), and as a result often spent up to 17 hours a day locked in their cells.
For those who were employed, the daily rate of pay was approximately
one dollar.
In the late 1950s, the University of Maryland established a medical
research unit at MHC to conduct nontherapeutic research into various
infectious diseases. They created live-in facilities that had heating and
cooling systems, hot water, and color television. Research pay was two
dollars a day in addition to whatever income was derived from regular
employment. Roughly a third of all participants were housed in the
research unit. Although research participation was not a consideration in
parole decisions, not all prisoners were advised of this.
The prisoners’ suit alleged that their participation in the research
had, in fact, been coerced. They argued that they had been incapable of
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giving truly informed consent because of the dismal prison conditions,
overcrowding, and the research pay (which was significantly greater than
any other prison job). In short, the conditions of research participation
were so far superior to their regular standard of living that inmates were
rendered unable to choose freely from alternatives.
The court rejected the argument, holding that the researchers had
acted ethically with due care and concern for the participants, avoiding
harm, and communicating the risks and benefits of participation.
Furthermore, it opined that not only was there an absence of coercion, the
actions of MHC were “not incompatible with evolving standards of
decency” (Bailey v. Lally, 1979, p. 219).
Although the plaintiffs did not prevail in this case, the
circumstances giving rise to their claim nevertheless have influenced
policymakers. Current federal regulations have created a far different
standard for contemporary research in prisons, in part, in response to
alleged abuses such as those articulated in Bailey. Greater sensitivity to
the institutional context has resulted in guidelines that provide direction in
all of the areas of concern identified in Bailey.
Conclusion
“It is commonplace that the evolution of research ethics, and
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especially regulatory changes, is driven by scandal” (Moreno, 1998, p.
16).
In the United States, the lessons learned in more than a century of
human experimentation have contributed to the development of elaborate,
comprehensive, and sensitively drawn ethical guidelines. However, the
patchwork nature of regulations as well as gaps in both federal and state
law is revealed in the lack of a uniform and coherent national policy.
Combined with the increasingly complex and sophisticated world of
biobehavioral research, this regulatory inconsistency is extremely
troubling to both researchers and the public alike (see Brakel, 1996;
Hoffman, Schwartz, & DeRenzo, 2000). In response to the call for a more
unified and comprehensive oversight process, NBAC (2001) has outlined
a proposal to institute a policy of accountability that would extend to
privately funded research:
A credible, effective oversight system must apply to all research,
and all people are entitled to the dignity that comes with freely and
knowingly choosing whether to participate in research, as well as
to protection from undue research risks. There is still no such
single authority ... . Indeed, some areas of research are not only
uncontrolled, they are almost invisible .. . . The time has come to
have a single source of guidance for these emerging areas, one that
would be better positioned to effect change across all divisions of
the government and private sector, as well as to facilitate
development of specialized review bodies as needed ... . a new
independent oversight office that would have clear authority over
all other segments of the federal government and extend
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protections to the entire private sector for both domestic and
international research (66 F.R. 46001-46002).
A commitment to ethical prison research is not merely an abstract
theoretical statement of general beneficence. Ethical and legal issues
facing researchers in the 21st century are complex, and sometimes in
conflict with each other. Even where explicit guidelines exist, they do not
ensure adherence, nor do they relieve the investigator of the responsibility
for balancing difficult and competing concerns. Nonetheless, as
biobehavioral research matures alongside advances in science and
technology, it becomes increasingly imperative that researchers remain
informed of current legal and ethical issues, and strive to comply at every
level of protocol development and implementation. At a minimum, this
requires (i) an awareness of statutory and regulatory frameworks and legal
requirements, (ii) ongoing monitoring and adherence to the mandates of
legal precedence, and (iii) a philosophical as well as practical commitment
to evolving normative ethical principles.
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